November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 01, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreNovember 01, 2025
The early toxicity testing market is expanding rapidly, driven by its role in safety evaluation, environmental remediation, and green chemistry initiatives. Innovations like in vitro methods, the FDA's 3Rs Alternatives Program, and ToxCast data advances are reducing animal testing and streamlining drug development....
November 01, 2025
According to market projections, the oncology NGS sector is expected to grow from USD 508.95 million in 2024 to USD 2,193.49 million by 2034, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&D for new treatments and diagnoses....
November 01, 2025
According to market projections, the glycomics sector is expected to grow from USD 2.21 billion in 2024 to USD 8.66 billion by 2034, reflecting a CAGR of 14.64%. The glycomics field is growing significantly due to its applications in drug discovery, disease diagnosis, therapeutics, and personalized medicine....
November 01, 2025
Single-use pumps are revolutionizing biopharmaceutical production by cutting costs and downtime. These pumps eliminate cleaning needs, reduce contamination risks, and ensure consistent pressure and flow. Ideal for handling large molecules, they streamline drug production with efficiency and reliability....
November 01, 2025
Induced pluripotent stem cells (iPSCs) are versatile cells derived from adult skin or blood, capable of transforming into any cell type. Widely used in regenerative medicine, disease modeling, and drug discovery, iPSCs are driving innovation, fueled by rising R&D and investment in stem cell therapies....
November 01, 2025
The macular edema and macular degeneration market is growing rapidly due to the prevalence of diabetic retinopathy and advancements in treatments like gene therapy and AI-based devices. Innovations, including FDA-approved EYLEA HD and OrCam MyEye, highlight progress in addressing vision loss globally....
November 01, 2025
Tissue clearing is a technique that makes biological tissues transparent for better microscopy visualization. Combined with fluorescent labeling and advanced imaging, it enables detailed 3D analysis. AI enhances this process by improving tissue imaging, data analysis, and accelerating research in fields like cancer and neurology....
November 01, 2025
The multiomics market is advancing with key funding rounds: PrognomiQ raised $34M (Nov 2024) to enhance disease monitoring, and Freenome secured $254M (Feb 2024) for early cancer detection tests. AI integration drives breakthroughs in data analysis, precision medicine, and drug discovery (e.g., MultiOmic Health)....
November 01, 2025
G-protein-coupled receptors (GPCRs) are critical targets in treating various diseases, including cardiovascular conditions. Recent investments, such as Superluminal's $120 million Series A funding and St. Jude's research collaboration, highlight the growing focus on developing innovative GPCR-targeting therapies, including AI-driven drug discovery....
November 01, 2025
According to market projections, the IV bags sector is expected to grow from USD 1.94 billion in 2024 to USD 3.52 billion by 2034, reflecting a CAGR of 6.14%. The rising geriatric population, increasing acute and chronic disorders, rising adoption of intravenous therapies, and increasing healthcare investments drive the market....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com